Latest / Healthcare NOW Radio Podcast Network - Discussions on healthcare including technology, innovation, policy, data security, telehealth and more. Visit HealthcareNOWRadio.com
Unscripted the AMCP Podcast: HER2-Positive Biliary Tract Cancer
HER2-Positive Biliary Tract Cancer: Biomarkers, Targeted Therapy, and Managed Care Access On this episode, Jeffrey Dunn, PharmD, MBA, President and CEO of Cooperative Benefits Group, discusses the rapidly evolving treatment landscape for HER2-positive biliary tract cancer (BTC) and its implications for managed care. The discussion covers the importance of biomarker testing and molecular profiling in guiding targeted therapy, key NCCN guideline considerations across lines of treatment, and the clinical and economic impact of timely access to HER2-directed therapies. We also discuss…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.